Details

NameSymbolSector
WINDLAS BIOTECH LIMITEDWINDLASPharmaceuticals
Open
1060
High
1087.95
Low
1028.05
Close
1047.5
Volume
123563
Exchange
nse
Time
14/08

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Windlas Biotech is  
None
Estimated Stoploss of Windlas Biotech is ₹  
1087.95
Windlas Biotech has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Windlas Biotech is  
Unpredictableℹ
. 

Trend

Windlas Biotech is in  
Sideways trendℹ
. 
Price of Windlas Biotech is  
Upℹ
 by  

11.4

%. 
Target
Buy @ 

854.66

Sell @ 

1005.26

Volume

The trades of Windlas Biotech have been in  
Immenseℹ
 volume. 
The volume trades for Windlas Biotech are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Windlas Biotech is  

Up

 by  

69.2

% 

Valuation

The current market price of Windlas Biotech is  
Undervaluedℹ

Financials

Balance
The balance sheet of Windlas Biotech is:  

Balanced

Cashflow
Windlas Biotech has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 4cr

. It is  
Downℹ
 by  

500

%. 

(*Mar 2025)

47.55% i.e. ₹ 68cr earned in operatingℹ
51.75% i.e. ₹ 74cr spent in investingℹ
0.7% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Windlas Biotech has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 1cr

. It is  
Downℹ
 by  

66.67

%. 

(*Mar 2024)

50.23% i.e. ₹ 108cr earned in operatingℹ
42.79% i.e. ₹ 92cr spent in investingℹ
6.98% i.e. ₹ 15cr spent in financingℹ
0% in otherℹ
Income
The income of Windlas Biotech is  

₹ 215cr

 and  

Profit

 is :  

₹ 17cr

(*Jun 2025)

Windlas Biotech Profit is up by:  

6.25

% and Income is Up by:  

3.86

% 

(*Jun 2025)

The income of Windlas Biotech is  

₹ 207cr

 and  

Profit

 is :  

₹ 16cr

(*Mar 2025)

Windlas Biotech Profit is up by:  

6.67

% and Income is Up by:  

4.02

% 

(*Mar 2025)

The income of Windlas Biotech is  

₹ 199cr

 and  

Profit

 is :  

₹ 15cr

(*Dec 2024)

Windlas Biotech Profit is up by:  

0

% and Income is Up by:  

4.19

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.